Search Results 1181-1190 of 12416 for Birth Control Palette
A randomized, double-blinded, placebo-controlled study of continuous 6-hour IV infusions of CXL-1427 in hospitalized patients with systolic heart failure.
... control of symptoms. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
... population, with and without chronic gastroesophageal reflux disease. ... This study aims to determine cancer control at 2 years after study registration.
Third, we will identify, evaluate, and implement existing low cost technologies for measuring trunk control, the training outcome of critical importance ...
Participation eligibility · Pregnant women or women of reproductive ability who are unwilling to use 2 effective methods of contraception from the time of ...
The goal of the proposed study is to develop and validate a myoelectrically-controlled power-assist upper extremity exoskeleton (powered exoskeleton) to ...
Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.
Persons who are of childbearing potential who are unwilling to employ adequate contraception. Any of the following prior therapies: Major surgery ≤ 3 weeks ...
Share · Tweet . IMG-20432190. Home; researchers-identify-fah-mutation-wo-succinylacetone-767px. Fuel groundbreaking medical research! Help Fund Research.
The study is designed to recruit 45% of the study population with Chronic Kidney Disease (CKD). The trial will test the effects of low systolic blood ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.